183 related articles for article (PubMed ID: 26016145)
1. [Hodgkin's lymphoma and radiotherapy].
Datsenko PV; Panshin GA
Vopr Onkol; 2015; 61(1):45-51. PubMed ID: 26016145
[TBL] [Abstract][Full Text] [Related]
2. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
3. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U
Med Klin (Munich); 1992 Nov; 87(11):555-62. PubMed ID: 1281905
[TBL] [Abstract][Full Text] [Related]
5. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
6. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
McClain KL; Heise R; Day DL; Lee CK; Woods WG; Aeppli D
Am J Pediatr Hematol Oncol; 1990; 12(2):147-54. PubMed ID: 1696073
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L
Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744
[TBL] [Abstract][Full Text] [Related]
9. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
Bartlett NL; Rosenberg SA; Hoppe RT; Hancock SL; Horning SJ
J Clin Oncol; 1995 May; 13(5):1080-8. PubMed ID: 7537796
[TBL] [Abstract][Full Text] [Related]
10. [Intermediate results of the German Hodgkin's disease therapy study].
Onkologie; 1986 Jun; 9(3):159-62. PubMed ID: 2427983
[TBL] [Abstract][Full Text] [Related]
11. [Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Diehl V; Pfreundschuh M; Löffler M; Smith K; Rühl U; Georgii A; Hiller E; Gerhartz H
Onkologie; 1987 Apr; 10(2):62-6. PubMed ID: 2438613
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group].
Pfreundschuh M; Löffler M; Rühl U; Hiller E; Gerhartz H; Wilmanns W; Kirchner H; Schoppe W; Petsch S; Bartels H
Onkologie; 1988 Feb; 11(1):48-52. PubMed ID: 2452393
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U
Leuk Lymphoma; 1994 Jun; 14(1-2):79-89. PubMed ID: 7522721
[TBL] [Abstract][Full Text] [Related]
14. [Hodgkin's lymphoma].
Vecchi V
Pediatr Med Chir; 1984; 6(2):213-8. PubMed ID: 6085157
[TBL] [Abstract][Full Text] [Related]
15. Role of additional radiotherapy in advanced stages of Hodgkin's disease.
Meerwaldt JH; Coleman CN; Fischer RI; Lister TA; Diehl V
Ann Oncol; 1992 Sep; 3 Suppl 4():83-5. PubMed ID: 1280464
[TBL] [Abstract][Full Text] [Related]
16. Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study Group.
Loeffler M; Pfreundschuh M; Hasenclever D; Hiller E; Gerhartz H; Wilmanns W; Rohloff R; Rühl U; Kühn G; Fuchs R
Blut; 1988 Jun; 56(6):273-81. PubMed ID: 2454691
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy.
Lobo-Sanahuja F; García I; Barrantes JC; Barrantes M; González M; Jiménez R
Med Pediatr Oncol; 1994; 22(6):398-403. PubMed ID: 7512191
[TBL] [Abstract][Full Text] [Related]
18. Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Viviani S; Santoro A; Negretti E; Bonfante V; Valagussa P; Bonadonna G
Ann Oncol; 1990; 1(2):123-7. PubMed ID: 1706614
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
al-Idrissi HY; Ibrahim EM
Int J Cancer; 1991 Apr; 47(6):822-6. PubMed ID: 1707034
[TBL] [Abstract][Full Text] [Related]
20. Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
Engelhard M; Meusers P; Brittinger G; Brack N; Dornoff W; Enne W; Gassmann W; Gerhartz H; Hallek M; Heise J
Ann Oncol; 1991 Feb; 2 Suppl 2():177-80. PubMed ID: 1710919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
